U.S. Markets open in 2 hrs 28 mins

Alseres Pharmaceuticals, Inc. (ALSE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
50.000.00 (0.00%)
At close: 10:14AM EDT
People also watch
ADLSAMARCAPSKDUSAVXT
Full screen
Previous Close50.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume0
Market Cap306.35k
Beta2.16
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015
    Capital Cube2 years ago

    Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015

    Capitalcube gives Alseres Pharmaceuticals, Inc. a score of 25.Our analysis is based on comparing Alseres Pharmaceuticals, Inc. with the following peers – Threshold Pharmaceuticals, Inc., Cortex Pharmaceuticals, Inc., Navidea Biopharmaceuticals, Inc., IMRIS Inc., Eli Lilly and Company, International Isotopes Inc., Synthetic Biologics, Inc., Fonar Corporation, iCAD, Inc. and General Electric Company (THLD-US, CORX-US, NAVB-US, IMRSQ-US, […] (Read more...) The post Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015 appeared first on CapitalCube.

  • We're sorry this is all we were able to find about this topic.